Executive hiring changes reflect a broader biotech comeback

The biotech market is still in recovery mode, with the number of IPOs gradually rising in the years since 2022’s dismal low.

That upward trend is reflected in biotech executive hiring, too, both in terms of overall demand and the types of positions companies are looking to fill, according to Jason Hersh, CEO, co-founder, and managing partner of the life sciences and healthcare executive search firm Klein Hersh.